ID: ALA524809

Max Phase: Preclinical

Molecular Formula: C25H38N2O2

Molecular Weight: 398.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCCCCCCCCn1ccnc1)O2

Standard InChI:  InChI=1S/C25H38N2O2/c1-19-20(2)24-22(21(3)23(19)28)12-14-25(4,29-24)13-10-8-6-5-7-9-11-16-27-17-15-26-18-27/h15,17-18,28H,5-14,16H2,1-4H3/t25-/m1/s1

Standard InChI Key:  MLGXSNGGDPGAOF-RUZDIDTESA-N

Associated Targets(Human)

Cytochrome P450 4F2 83 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 3A4 53859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 398.59Molecular Weight (Monoisotopic): 398.2933AlogP: 6.42#Rotatable Bonds: 10
Polar Surface Area: 47.28Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.80CX Basic pKa: 6.54CX LogP: 7.03CX LogD: 6.99
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.47Np Likeness Score: 0.70

References

1. Ohnmacht S, Nava P, West R, Parker R, Atkinson J..  (2008)  Inhibition of oxidative metabolism of tocopherols with omega-N-heterocyclic derivatives of vitamin E.,  16  (16): [PMID:18656365] [10.1016/j.bmc.2008.07.020]

Source